Radiant Innovation

Radiant Innovation Rule of 40

The Rule of 40 of Radiant Innovation (3373.TWO) as of Oct 22, 2026 is -25.99 %. In the previous year, Rule of 40 was -13.52 % — a change of 92.26% (lower).

Rule of 40

-25.99 %

YoY

92.26%

Last updated:

Rule of 40 of Radiant Innovation is 2025 -25.99 % . Rule of 40 of Radiant Innovation was 2024 -13.52 % . It decreases by 92.26% lower compared to the previous year.

The Radiant Innovation Rule of 40 history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Rule of 40
Date
Rule of 40
Jan 1, 2018
6.98 TWD
Jan 1, 2019
0.14 TWD
Jan 1, 2020
269.73 TWD
Jan 1, 2021
-47.18 TWD
Jan 1, 2022
-45.38 TWD
Jan 1, 2023
-44.07 TWD
Jan 1, 2024
-13.52 TWD
Jan 1, 2025
-25.99 TWD
The Radiant Innovation Rule of 40 history
YEARRule of 40YoY
-25.99 %+92.26%
-13.52 %-69.33%
-44.07 %-2.87%
-45.38 %-3.83%
-47.18 %-117.49%
269.73 %+191,597.57%
0.14 %-97.98%
6.98 %-366.62%
-2.62 %-21.27%
-3.33 %-110.84%
30.67 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Radiant Innovation Stock analysis

What does Radiant Innovation do? Radiant Innovation Inc. generates revenue through the design, manufacture, and sale of infrared technology products. The company's main products include infrared temperature measurement instruments, ear temperature guns, frontal temperature guns, and other body temperature measurement products, alongside carbon dioxide detectors, infrared thermal imagers, and blood glucose dedicated chipsets. These products are distributed domestically and internationally across Asia, the Americas, Europe, and other regions. The primary buyers are healthcare providers, medical facilities, and electronic component distributors who require precise measurement tools and specialized components for health monitoring and diagnostics. The firm's product portfolio targets healthcare and industrial segments, with infrared thermal imagers used in building inspections and carbon dioxide detectors deployed in environmental monitoring. Blood glucose dedicated chipsets are supplied to medical device manufacturers for integration into diagnostic equipment. International distribution channels focus on regions like Asia, the Americas, and Europe, where demand for health-related measurement devices remains strong. Revenue streams are driven by direct sales to medical institutions, electronic component distributors, and industrial clients. The company's product lines serve both consumer-facing health monitoring applications and specialized industrial uses, with a strong emphasis on accuracy and reliability in temperature and gas detection technologies. Radiant Innovation is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Radiant Innovation stock

Rule of 40 of Radiant Innovation is -25.99 % in 2025.

On Eulerpool you can find the complete historical development of Rule of 40 Radiant Innovation since 2006 – with annual values, charts, and detailed analysis.

The Rule of 40 states that a company's revenue growth rate plus profit margin should exceed 40%. It is widely used to evaluate SaaS and high-growth companies.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Quality — Radiant Innovation

All Key Metrics — Radiant Innovation